Ruwan Wijayamuni

556 total citations
12 papers, 142 citations indexed

About

Ruwan Wijayamuni is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ruwan Wijayamuni has authored 12 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 3 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ruwan Wijayamuni's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 epidemiological studies (3 papers). Ruwan Wijayamuni is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 epidemiological studies (3 papers). Ruwan Wijayamuni collaborates with scholars based in Sri Lanka, United Kingdom and Singapore. Ruwan Wijayamuni's co-authors include May O. Lwin, Schubert Foo, Chandima Jeewandara, Anita Sheldenkar, Dinuka Guruge, Graham S. Ogg, Deshni Jayathilaka, Gathsaurie Neelika Malavige, Kacey C. Ernst and Laksiri Gomes and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ruwan Wijayamuni

12 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruwan Wijayamuni Sri Lanka 7 81 43 27 21 17 12 142
Dinuka Guruge Sri Lanka 7 87 1.1× 33 0.8× 9 0.3× 22 1.0× 10 0.6× 11 136
Martha Lucía Ospina Martínez Colombia 7 140 1.7× 106 2.5× 25 0.9× 16 0.8× 12 0.7× 11 195
Rajni Kant India 8 88 1.1× 74 1.7× 13 0.5× 19 0.9× 5 0.3× 34 169
Jurandy Júnior Ferraz de Magalhães Brazil 6 91 1.1× 39 0.9× 26 1.0× 16 0.8× 15 0.9× 14 154
Chun Huang China 9 96 1.2× 28 0.7× 35 1.3× 11 0.5× 5 0.3× 14 168
Chinedu Arinze Nigeria 5 57 0.7× 22 0.5× 34 1.3× 32 1.5× 4 0.2× 7 154
Nicola Lorusso Spain 6 45 0.6× 24 0.6× 10 0.4× 25 1.2× 14 0.8× 19 122
Jazeel Abdulmajeed Qatar 7 57 0.7× 38 0.9× 16 0.6× 11 0.5× 2 0.1× 27 147
Jinzhao Cui China 7 91 1.1× 12 0.3× 72 2.7× 22 1.0× 10 0.6× 11 165
Conan Zhao United States 7 105 1.3× 27 0.6× 119 4.4× 46 2.2× 10 0.6× 10 253

Countries citing papers authored by Ruwan Wijayamuni

Since Specialization
Citations

This map shows the geographic impact of Ruwan Wijayamuni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruwan Wijayamuni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruwan Wijayamuni more than expected).

Fields of papers citing papers by Ruwan Wijayamuni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruwan Wijayamuni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruwan Wijayamuni. The network helps show where Ruwan Wijayamuni may publish in the future.

Co-authorship network of co-authors of Ruwan Wijayamuni

This figure shows the co-authorship network connecting the top 25 collaborators of Ruwan Wijayamuni. A scholar is included among the top collaborators of Ruwan Wijayamuni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruwan Wijayamuni. Ruwan Wijayamuni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Jayathilaka, Deshni, Chandima Jeewandara, Laksiri Gomes, et al.. (2022). Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222. Clinical & Experimental Immunology. 208(3). 323–331. 5 indexed citations
2.
Jeewandara, Chandima, Heshan Kuruppu, Dinuka Guruge, et al.. (2022). Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka. SHILAP Revista de lepidopterología. 2(7). e0000607–e0000607. 3 indexed citations
3.
Jayadas, Tibutius T. P., Deshni Jayathilaka, Chandima Jeewandara, et al.. (2022). Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR. PLoS ONE. 17(4). e0265220–e0265220. 11 indexed citations
4.
Jayathilaka, Deshni, Chandima Jeewandara, Tibutius T. P. Jayadas, et al.. (2022). Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka. Frontiers in Public Health. 10. 873633–873633. 8 indexed citations
5.
Jeewandara, Chandima, Dinuka Guruge, Tibutius T. P. Jayadas, et al.. (2022). Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection. BMC Infectious Diseases. 22(1). 276–276. 14 indexed citations
6.
Jeewandara, Chandima, et al.. (2022). Memory B Cell Responses at 16 Weeks Following a Single Dose of AZD1222/Covishield in Sri Lankan Individuals. International Journal of Infectious Diseases. 116. S63–S63. 2 indexed citations
7.
Jeewandara, Chandima, Deshni Jayathilaka, Laksiri Gomes, et al.. (2021). SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness. Scientific Reports. 11(1). 2062–2062. 29 indexed citations
8.
Jeewandara, Chandima, Dinuka Guruge, Deshni Jayathilaka, et al.. (2021). Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020. PLoS ONE. 16(11). e0257548–e0257548. 5 indexed citations
9.
Kamaladasa, Achala, Chandima Jeewandara, Deshni Jayathilaka, et al.. (2021). Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients. International Journal of Infectious Diseases. 109. 85–89. 2 indexed citations
10.
Sheldenkar, Anita, et al.. (2019). Developing a Digital Solution for Dengue Through Epihack: Qualitative Evaluation Study of a Five-Day Health Hackathon in Sri Lanka. JMIR Formative Research. 3(3). e11555–e11555. 6 indexed citations
11.
Lwin, May O., et al.. (2017). Lessons From the Implementation of Mo-Buzz, a Mobile Pandemic Surveillance System for Dengue. JMIR Public Health and Surveillance. 3(4). e65–e65. 33 indexed citations
12.
Lwin, May O., et al.. (2016). A Social Media mHealth Solution to Address the Needs of Dengue Prevention and Management in Sri Lanka. Journal of Medical Internet Research. 18(7). e149–e149. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026